vs
阿普塔集团（ATR）与CoStar Group（CSGP）财务数据对比。点击上方公司名可切换其他公司
阿普塔集团的季度营收约是CoStar Group的1.1倍（$962.7M vs $899.9M），阿普塔集团净利率更高（7.7% vs 5.2%，领先2.6%），CoStar Group同比增速更快（26.9% vs 13.5%），CoStar Group自由现金流更多（$101.3M vs $96.9M），过去两年CoStar Group的营收复合增速更高（17.1% vs 2.6%）
阿普塔集团（AptarGroup, Inc.）是总部位于美国的全球性制造企业，主营消费品分配包装产品及药物给药装置的研发与生产，目前在全球18个国家设有生产运营基地，服务医药、快消等多领域客户。
CoStar Group是1987年成立的美国商业地产服务商，总部位于弗吉尼亚州阿灵顿，业务覆盖北美、欧洲地区，为商业地产行业提供信息、分析及营销解决方案，旗下运营CoStar线上数据库、新闻网站及Apartments.com、Homes.com等多个线上平台。
ATR vs CSGP — 直观对比
营收规模更大
ATR
是对方的1.1倍
$899.9M
营收增速更快
CSGP
高出13.3%
13.5%
净利率更高
ATR
高出2.6%
5.2%
自由现金流更多
CSGP
多$4.4M
$96.9M
两年增速更快
CSGP
近两年复合增速
2.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $962.7M | $899.9M |
| 净利润 | $74.3M | $46.5M |
| 毛利率 | — | 78.6% |
| 营业利润率 | 11.0% | 5.5% |
| 净利率 | 7.7% | 5.2% |
| 营收同比 | 13.5% | 26.9% |
| 净利润同比 | -26.4% | -22.2% |
| 每股收益（稀释后） | $1.13 | $0.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ATRCSGP
| Q4 25 | $962.7M | $899.9M | ||
| Q3 25 | $961.1M | $833.6M | ||
| Q2 25 | $966.0M | $781.3M | ||
| Q1 25 | $887.3M | $732.2M | ||
| Q4 24 | $848.1M | $709.4M | ||
| Q3 24 | $909.3M | $692.6M | ||
| Q2 24 | $910.1M | $677.8M | ||
| Q1 24 | $915.4M | $656.4M |
净利润ATRCSGP
| Q4 25 | $74.3M | $46.5M | ||
| Q3 25 | $127.9M | $-30.9M | ||
| Q2 25 | $111.7M | $6.2M | ||
| Q1 25 | $78.8M | $-14.8M | ||
| Q4 24 | $100.9M | $59.8M | ||
| Q3 24 | $100.0M | $53.0M | ||
| Q2 24 | $90.5M | $19.2M | ||
| Q1 24 | $83.1M | $6.7M |
毛利率ATRCSGP
| Q4 25 | — | 78.6% | ||
| Q3 25 | — | 79.3% | ||
| Q2 25 | — | 78.5% | ||
| Q1 25 | — | 79.1% | ||
| Q4 24 | — | 80.1% | ||
| Q3 24 | — | 79.7% | ||
| Q2 24 | — | 80.0% | ||
| Q1 24 | — | 78.5% |
营业利润率ATRCSGP
| Q4 25 | 11.0% | 5.5% | ||
| Q3 25 | 14.2% | -6.1% | ||
| Q2 25 | 14.9% | -3.5% | ||
| Q1 25 | 12.8% | -5.8% | ||
| Q4 24 | 14.2% | 5.6% | ||
| Q3 24 | 15.2% | 3.4% | ||
| Q2 24 | 13.8% | -2.4% | ||
| Q1 24 | 12.2% | -6.5% |
净利率ATRCSGP
| Q4 25 | 7.7% | 5.2% | ||
| Q3 25 | 13.3% | -3.7% | ||
| Q2 25 | 11.6% | 0.8% | ||
| Q1 25 | 8.9% | -2.0% | ||
| Q4 24 | 11.9% | 8.4% | ||
| Q3 24 | 11.0% | 7.7% | ||
| Q2 24 | 9.9% | 2.8% | ||
| Q1 24 | 9.1% | 1.0% |
每股收益（稀释后）ATRCSGP
| Q4 25 | $1.13 | $0.12 | ||
| Q3 25 | $1.92 | $-0.07 | ||
| Q2 25 | $1.67 | $0.01 | ||
| Q1 25 | $1.17 | $-0.04 | ||
| Q4 24 | $1.48 | $0.14 | ||
| Q3 24 | $1.48 | $0.13 | ||
| Q2 24 | $1.34 | $0.05 | ||
| Q1 24 | $1.23 | $0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $409.5M | $1.6B |
| 总债务越低越好 | $1.1B | $140.0M |
| 股东权益账面价值 | $2.7B | $8.3B |
| 总资产 | $5.3B | $10.5B |
| 负债/权益比越低杠杆越低 | 0.43× | 0.02× |
8季度趋势，按日历期对齐
现金及短期投资ATRCSGP
| Q4 25 | $409.5M | $1.6B | ||
| Q3 25 | $264.8M | $1.9B | ||
| Q2 25 | $169.8M | $3.6B | ||
| Q1 25 | $136.8M | $3.7B | ||
| Q4 24 | $226.2M | $4.7B | ||
| Q3 24 | $327.9M | — | ||
| Q2 24 | $223.9M | — | ||
| Q1 24 | $201.1M | — |
总债务ATRCSGP
| Q4 25 | $1.1B | $140.0M | ||
| Q3 25 | $546.0M | $1.0B | ||
| Q2 25 | $535.1M | $1.0B | ||
| Q1 25 | $561.2M | $1.0B | ||
| Q4 24 | $688.1M | $1.0B | ||
| Q3 24 | $822.7M | $1.0B | ||
| Q2 24 | $681.5M | $1.0B | ||
| Q1 24 | $680.4M | $1.0B |
股东权益ATRCSGP
| Q4 25 | $2.7B | $8.3B | ||
| Q3 25 | $2.8B | $8.6B | ||
| Q2 25 | $2.7B | $8.6B | ||
| Q1 25 | $2.5B | $8.6B | ||
| Q4 24 | $2.5B | $7.6B | ||
| Q3 24 | $2.5B | $7.5B | ||
| Q2 24 | $2.4B | $7.4B | ||
| Q1 24 | $2.3B | $7.3B |
总资产ATRCSGP
| Q4 25 | $5.3B | $10.5B | ||
| Q3 25 | $5.1B | $10.8B | ||
| Q2 25 | $4.9B | $10.5B | ||
| Q1 25 | $4.5B | $10.4B | ||
| Q4 24 | $4.4B | $9.3B | ||
| Q3 24 | $4.6B | $9.1B | ||
| Q2 24 | $4.5B | $9.1B | ||
| Q1 24 | $4.4B | $9.0B |
负债/权益比ATRCSGP
| Q4 25 | 0.43× | 0.02× | ||
| Q3 25 | 0.20× | 0.12× | ||
| Q2 25 | 0.20× | 0.12× | ||
| Q1 25 | 0.22× | 0.12× | ||
| Q4 24 | 0.28× | 0.13× | ||
| Q3 24 | 0.32× | 0.13× | ||
| Q2 24 | 0.28× | 0.14× | ||
| Q1 24 | 0.29× | 0.14× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $183.7M | $162.1M |
| 自由现金流经营现金流 - 资本支出 | $96.9M | $101.3M |
| 自由现金流率自由现金流/营收 | 10.1% | 11.3% |
| 资本支出强度资本支出/营收 | 9.0% | 6.8% |
| 现金转化率经营现金流/净利润 | 2.47× | 3.49× |
| 过去12个月自由现金流最近4个季度 | $299.6M | $123.0M |
8季度趋势，按日历期对齐
经营现金流ATRCSGP
| Q4 25 | $183.7M | $162.1M | ||
| Q3 25 | $177.6M | $68.2M | ||
| Q2 25 | $126.0M | $146.5M | ||
| Q1 25 | $82.7M | $53.2M | ||
| Q4 24 | $178.2M | $94.6M | ||
| Q3 24 | $229.3M | $100.3M | ||
| Q2 24 | $143.6M | $58.1M | ||
| Q1 24 | $92.3M | $139.6M |
自由现金流ATRCSGP
| Q4 25 | $96.9M | $101.3M | ||
| Q3 25 | $114.3M | $-5.5M | ||
| Q2 25 | $62.5M | $27.7M | ||
| Q1 25 | $25.9M | $-500.0K | ||
| Q4 24 | $112.2M | $25.2M | ||
| Q3 24 | $162.7M | $40.2M | ||
| Q2 24 | $75.4M | $-14.7M | ||
| Q1 24 | $16.7M | $-237.1M |
自由现金流率ATRCSGP
| Q4 25 | 10.1% | 11.3% | ||
| Q3 25 | 11.9% | -0.7% | ||
| Q2 25 | 6.5% | 3.5% | ||
| Q1 25 | 2.9% | -0.1% | ||
| Q4 24 | 13.2% | 3.6% | ||
| Q3 24 | 17.9% | 5.8% | ||
| Q2 24 | 8.3% | -2.2% | ||
| Q1 24 | 1.8% | -36.1% |
资本支出强度ATRCSGP
| Q4 25 | 9.0% | 6.8% | ||
| Q3 25 | 6.6% | 8.8% | ||
| Q2 25 | 6.6% | 15.2% | ||
| Q1 25 | 6.4% | 7.3% | ||
| Q4 24 | 7.8% | 9.8% | ||
| Q3 24 | 7.3% | 8.7% | ||
| Q2 24 | 7.5% | 10.7% | ||
| Q1 24 | 8.3% | 57.4% |
现金转化率ATRCSGP
| Q4 25 | 2.47× | 3.49× | ||
| Q3 25 | 1.39× | — | ||
| Q2 25 | 1.13× | 23.63× | ||
| Q1 25 | 1.05× | — | ||
| Q4 24 | 1.77× | 1.58× | ||
| Q3 24 | 2.29× | 1.89× | ||
| Q2 24 | 1.59× | 3.03× | ||
| Q1 24 | 1.11× | 20.84× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ATR
| Pharma Segment | $833.1M | 87% |
| Other | $129.6M | 13% |
CSGP
| Co Star | $503.8M | 56% |
| Other | $283.0M | 31% |
| Loop Net | $94.7M | 11% |
